- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02663778
Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults: Program to Improve Mobility in Aging (PRIMA)
September 17, 2021 updated by: Jennifer S. Brach, University of Pittsburgh
Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults
This randomized clinical trial targets 248 community-dwelling older adults with impaired mobility (i.e.
walking slowly; gait speed < 1.20 m/s).
The trial compares a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training to a standard 12 week strength, endurance and flexibility program.
The primary outcome is gait speed at 12 weeks.
Secondary and tertiary outcomes represent components of the intervention and measures of activity and participation.
Delayed and sustained effects of the intervention are examined at 24 and 36 weeks.
Study Overview
Status
Completed
Conditions
Detailed Description
Walking difficulty is common and costly in older adults.
While traditional exercise has been shown to promote physical and mental health and may prevent walking difficulty, such exercise has focused on strength and endurance, and has overlooked a critical component of walking ability; the timing and coordination of movement.
Aging and disease alter timing and coordination as reflected by slowed neuromotor performance, increased gait variability and reduced smoothness of movement.
Task specific timing and coordination exercise that includes practice of smooth coordinated aspects of gait over multiple walking conditions has the potential to improve walking ability greater than a standard program.
Our preliminary data suggest that interventions on timing and coordination of gait impact mobility greater than the standard strength and endurance program.
The next key step and the objective of this proposal is to combine the two interventions to determine if potential gains in mobility, activity and participation obtained from a standard plus timing and coordination program, are larger than the gains obtained from the standard program alone.
Therefore, the primary aim of the proposed project is to evaluate the impact of adding timing and coordination training to standard strength and endurance training on mobility.
Secondary aims include examining 1) additional outcomes representing the components of the intervention and measures of activity and participation, 2) the delayed and sustained effects of the intervention, and 3) the effects of the intervention within various other subgroups of interest.
This randomized clinical trial in 248 community-dwelling older adults who walk slowly (i.e.
< 1.20 m/s) will compare a standard 12 week strength, endurance and flexibility program to a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training.
The primary outcome is gait speed at 12 weeks.
We will also examine secondary and tertiary outcomes representing components of the intervention and measures of activity and participation and the delayed and sustained effects at 24 and 36 weeks.
The findings from this efficacy trial will provide evidence for the added value of task specific timing and coordination training for promoting walking ability in older adults and will form the basis for future effectiveness trials.
Future work includes translation to nonprofessional exercise leaders with the long-term goal to incorporate neurological training into standard exercise programs for health promotion for older adults.
Study Type
Interventional
Enrollment (Actual)
353
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15219
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 65 years of age and older
- Ambulatory without an assistive device or the assistance of another person
- Usual 4 meter gait speed > 0.60 m/s and < 1.2 m/s
- Physician clearance to participate in a moderate intensity exercise program
- Not meeting physical activity recommendations defined as reporting less than 150 minutes of moderate intensity activity per week in the past month.7
Exclusion Criteria:
- persistent lower extremity pain that is present on most days of the week
- back pain that is present on most days of the weeks and interferes with walking and activities of daily living or back pain that increases with walking
- refuse to walk on a treadmill
- plans to move out of the area in the next 5 years
- dyspnea at rest or during activities of daily living or use supplemental oxygen (CHF, COPD)
- any acute illness or medical condition that is not stable according to the approving physician
- resting systolic blood pressure ≥ 200 mm Hg or diastolic blood pressure ≥ 100 mm Hg or resting heart rate > 100 or < 40 beats per minute
- diagnosed dementia or cognitive impairment defined as modified Mini-Mental State (3MS) examination <79
- hospitalized in the past 6 months for acute illness or surgery, other than minor surgical procedures
- severe visual impairment
- fixed or fused lower extremity joints such as hip, knee or ankle
- lower extremity strength <3/5 on manual muscle testing
- lower extremity amputation
- progressive movement disorder such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis or Parkinson's disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard
The standard arm consists of strength, endurance and flexibility exercises 2 times per week for 12 weeks.
Will also receive a physical activity behavioral intervention.
|
weight lifting to increase muscle strength
treadmill walking to increase endurance
stretches to improve flexibility
Intervention to encourage participants to be more physically active
|
Experimental: Standard-plus
The standard-plus arm consists of strength, endurance and flexibility exercises plus task specific timing and coordination exercises to improve gait 2 times per week for 12 weeks.
Will also receive a physical activity behavioral intervention.
|
weight lifting to increase muscle strength
treadmill walking to increase endurance
stretches to improve flexibility
Intervention to encourage participants to be more physically active
stepping and walking patterns to improve timing and coordination of gait
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait speed
Time Frame: 12 weeks
|
Usual walking speed over a short distance.
A physiologic measure recorded in m/s.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoothness of walking
Time Frame: 12, 24, and 36 weeks
|
acceleration signal of usual walking.
physiologic measure of the acceleration of walking.
|
12, 24, and 36 weeks
|
gait variability
Time Frame: 12, 24, 36 weeks
|
fluctuations in gait characteristics from step to step.
physiologic measure of the spatial and temporal gait characteristics
|
12, 24, 36 weeks
|
Late Life Function and Disability Instrument - function subscale
Time Frame: 12, 24, and 36 weeks
|
Self report measure of function
|
12, 24, and 36 weeks
|
Late Life Function and Disability Instrument - disability subscale
Time Frame: 12, 24, and 36 weeks
|
Self report measure of disability
|
12, 24, and 36 weeks
|
Lower extremity strength
Time Frame: 12, 24, and 36 weeks
|
physiologic measure of leg strength
|
12, 24, and 36 weeks
|
Lower extremity muscle power
Time Frame: 12, 24, and 36 weeks
|
physiologic measure of leg muscle power
|
12, 24, and 36 weeks
|
Six minute walk test
Time Frame: 12, 24, and 36 weeks
|
physiologic measure of walking endurance
|
12, 24, and 36 weeks
|
Chair sit and reach test
Time Frame: 12, 24, and 36 weeks
|
physiologic measure of flexibility
|
12, 24, and 36 weeks
|
Physical activity
Time Frame: 12, 24, and 36 weeks
|
Physiologic measure of physical activity measured using an accelerometer.
|
12, 24, and 36 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Falls
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Self reported falls collected monthly by telephone
|
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Emergency room visits
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Self reported emergency room visits collected monthly by telephone
|
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Hospital admission
Time Frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Self reported hospital admission collected monthly by telephone
|
16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer S Brach, PhD, PT, University of Pittsburgh
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Actual)
January 1, 2020
Study Completion (Actual)
February 1, 2021
Study Registration Dates
First Submitted
January 21, 2016
First Submitted That Met QC Criteria
January 25, 2016
First Posted (Estimate)
January 26, 2016
Study Record Updates
Last Update Posted (Actual)
September 20, 2021
Last Update Submitted That Met QC Criteria
September 17, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO14080080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gait, Unsteady
-
University of ChicagoRecruiting
-
Samsung Medical CenterCompletedHealthy | Gait, UnsteadyKorea, Republic of
-
Umm Al-Qura UniversityRecruiting
-
University of PittsburghNational Institute on Aging (NIA)Withdrawn
-
Istituto Ortopedico GaleazziCompleted
-
University of Applied Sciences of Western SwitzerlandUnknown
-
Hebrew SeniorLifeNational Institute on Aging (NIA)Not yet recruitingFall | Mobility Limitation | Gait, UnsteadyUnited States
-
University of MalagaCompletedChild, Only | Gait, UnsteadySpain
-
Texas Tech University Health Sciences CenterTexas Tech UniversityWithdrawnGait, Unsteady | Accidental FallsUnited States
-
Central Arkansas Veterans Healthcare SystemCompleted
Clinical Trials on Strength training
-
University of AarhusUnknownOsteoarthritis, KneeDenmark
-
University of FloridaCompleted
-
Universidad Autónoma de Manizales, ColombiaCompletedFemale | Volleyball | PlayerColombia
-
Norwegian University of Science and TechnologyCompleted
-
Christian DallCompletedHeart Failure | Ischemic Heart Disease | Heart Transplant RecipientsDenmark
-
Lislei Jorge PatrizziCompleted
-
Eunice Kennedy Shriver National Institute of Child...Shriners Hospitals for Children; University of DelawareUnknownSpastic Diplegic Cerebral PalsyUnited States
-
Isra UniversityCompleted
-
Vrije Universiteit BrusselRecruitingHealthy Aged VolunteersBelgium
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany